Top Markets
#1 Cortex Cortex +173.34%
#2 GEKKO GEKKO +52.86%
#3 Helium Helium +19.19%
#4 ADO Protocol ADO Protocol +18.03%
#5 Audiera Audiera +12.56%
#6 o1.exchange o1.exchange +11.76%
#7 Bless Bless +11.17%
#8 Seeker Seeker +10.51%
#9 Status Status +9.43%
#10 aelf aelf +8.71%
Coin of the day
Cortex Cortex
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Pozycja w akcjach #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Cena akcji
$59.98
Ostatnia synchronizacja: 2024-12-13
Kapitalizacja rynkowa
$1.22B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Longboard Pharmaceuticals, Inc. (LBPH)

Kategoria

Healthcare
Zyski dla Longboard Pharmaceuticals, Inc. (LBPH)
Zyski w Sep 2024 TTM: $-76.34M
Według najnowszych raportów finansowych Longboard Pharmaceuticals, Inc., obecny zysk firmy wynosi $-76.34M. W roku 2022 firma osiągnęła zysk w wysokości $-43.95M, spadek w porównaniu do zysku z roku 2021, który wynosił $-27.80M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Longboard Pharmaceuticals, Inc. od 2020 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-76.34M 40.28%
2023 $-54.42M 23.84%
2022 $-43.95M 58.09%
2021 $-27.80M 93.03%
2020 $-14.40M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -7,009.38%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -2,655.08%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B 5,160.66%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B 3,943.54%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH